Investment objective & strategy
As of Jan. 28, 2026 · prospectusObjective. The Funds investment objective is long-term growth of capital.
Strategy. The Fund invests primarily in small companies. Under normal market conditions, we will invest at least 80% of the Funds net assets (plus borrowings for investment purposes) in the equity securities, typically common stock, of small-capitalization companies. The Fund considers a company to be a small-capitalization company if its market capitalization, at the time of purchase, is less than the larger of $3 billion or the market capitalization of the largest company in the Russell 2000 Index as of its most recent reconstitution date. The Russell 2000 Index reconstitution date is typically each year on or around July 1. As of the 2025 reconstitution date, the market capitalization of companies included in the Russell 2000 Index ranged from $ 61 … The Fund invests primarily in small companies. Under normal market conditions, we will invest at least 80% of the Funds net assets (plus borrowings for investment purposes) in the equity securities, typically common stock, of small-capitalization companies. The Fund considers a company to be a small-capitalization company if its market capitalization, at the time of purchase, is less than the larger of $3 billion or the market capitalization of the largest company in the Russell 2000 Index as of its most recent reconstitution date. The Russell 2000 Index reconstitution date is typically each year on or around July 1. As of the 2025 reconstitution date, the market capitalization of companies included in the Russell 2000 Index ranged from $ 61 million to $ 16.033 billion. The market capitalizations for the range of companies in the Russell 2000 Index are subject to change at its next reconstitution date. The Fund may invest up to 20% of its total assets at the time of purchase in securities issued by foreign companies (companies that are incorporated in any country outside the United States and whose securities principally trade outside the United States). Securities issued by companies incorporated outside the United States whose securities are principally traded in the United States are not defined as foreign companies and are not subject to this limitation. The Fund may also invest in growth companies if the Advisor believes that current valuation is at a sufficient discount to a companys projected long-term earnings growth rate. The Funds secondary objective of income is achieved when portfolio companies pay dividends. We use a bottom-up process of fundamental analysis to look for individual companies that we believe are temporarily undervalued but have significant potential for stock price appreciation. Our analysis may include studying a companys financial statements, visiting company facilities, and meeting with executive management, suppliers and customers. We typically look for companies that we believe fall into one of the following three categories at the time of purchase: Undiscovered Gems Companies with good growth potential that have yet to be broadly discovered by Wall Street analysts, thus leaving them attractively undervalued relative to their expected growth rate. Fallen Angels High quality growth companies that have experienced a temporary setback and therefore have appealing valuations relative to their long-term growth potential. Quality Value Quality companies with earnings potential that is not fully reflected in their stock prices. The Fund may invest a large percentage of its assets (greater than 5%) in a few sectors. As of the date of this Prospectus, these sectors were industrials , financials , consumer discretionary, information technology, health care, and consumer staples .
Top holdings
As of March 31, 2026 · N-PORT| Security | Ticker | Value | % of fund |
|---|---|---|---|
| KADANT INC | — | $39.15M | 2.97% |
| BANK OZK | — | $37.68M | 2.86% |
| ALLISON TRANSMISSION HLDGS INC | — | $36.94M | 2.80% |
| MEDPACE HOLDINGS INC | — | $35.67M | 2.70% |
| CTS CORP | — | $33.88M | 2.57% |
| MOELIS & CO-CL A | — | $33.50M | 2.54% |
| HEALTHEQUITY INC | — | $33.44M | 2.54% |
| STANDEX INTL CORP | — | $32.30M | 2.45% |
| ENSIGN GROUP INC | — | $31.74M | 2.41% |
| UFP INDUSTRIES INC | — | $31.44M | 2.38% |
Portfolio moves
Dec 31, 2025 → Mar 31, 2026How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.
Similar funds
Funds whose portfolios most overlap this one, by weight| Fund | Overlap | Net exp. |
|---|---|---|
| Wasatch Core Growth Fund · WGROX, WIGRX | 47% | 1.05% |
| Wasatch Long/Short Alpha Fund · WALSX, WGLSX | 42% | 2.01% |
| Wasatch Global Opportunities Fund · WAGOX, WIGOX | 32% | 1.35% |
Advisers
| Firm | Role |
|---|---|
| Wasatch Advisors LP | Adviser |
Footnotes
- Expense ratio as of January 28, 2026, from the fund's prospectus.
- Net assets and holdings count as of March 31, 2026, from the fund's N-PORT filing.
- Total return for calendar year 2025, before tax and after fund expenses. As reported in the fund's prospectus performance bar chart.
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.